Table 1. Patients characteristics.
| (n=55) | |
|---|---|
| Age (years) | |
| Mean±s.d. | 58.2±9.4 |
| Gender | |
| Male/female | 49/6 |
| Hepatitis virus | |
| HBsAg+, HCVAb− | 19 |
| HBsAg−, HCVAb+ | 24 |
| HBsAg+, HCVAb+ | 5 |
| HBsAg−, HCVAb− | 5 |
| Unknown | 2 |
| Granulocytes (μl −1 ) | |
| Mean±s.d. | 5310±1958 |
| Platelets ( × 104 μl−1) | |
| Mean±s.d. | 15.3±6.7 |
| Serum albumin (g dl −1 ) | |
| Mean±s.d. | 3.22±0.44 |
| Serum bilirubin (mg dl −1 ) | |
| Mean±s.d. | 0.94±0.36 |
| Prothrombin time (s) | |
| Mean±s.d. | 17.9±2.0 |
| Child–Pugh classification | |
| A | 19 |
| B | 31 |
| C | 4 |
| Unknown | 1 |
| AFP (ng ml −1 ) | |
| <5 | 2 |
| ⩾5 | 52 |
| Unknown | 1 |
| PIVKA-II (mAU ml −1 ) | |
| <40 | 2 |
| ⩾40 | 52 |
| Unknown | 1 |
| Tumour size (cm) | |
| Mean±s.d. | 6.4±3.2 |
HbsAg=hepatitis B serum antigen; HCVAb=hepatitis C viral antibody; AFP=alpha-fetoprotein; PIVKA-II= protein induced by vitamin K absence or antagonist-II.